Learning Objectives:
- To understand how angiogenesis and hypoxia contribute to tumor development and metastasis in
aggressive tumor types, including triple negative breast cancer
- To review failures of anti-hypoxia and anti-angiogenesis agents in triple negative breast cancer and
discuss the prognostic, predictive and therapeutic roles for hypoxia and angiogenesis in solid tumors
- To understand the importance of using patient-derived models in cancer research
Session date:
09/28/2023 - 8:00am to 9:00am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Margarite Matossian, MD